Healthcare provider profile · identity verified

Padma Gadela, MD

Internal Medicine · MINNEAPOLIS, MN · NPI 1174586101

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	601	163
Amlodipine Besylate	Amlodipine Besylate	474	133
Losartan Potassium	Losartan Potassium	385	118
Levothyroxine Sodium	Levothyroxine Sodium	380	97
Omeprazole	Omeprazole	330	106
Lisinopril	Lisinopril	322	85
Metformin Hcl	Metformin Hcl	305	83
Rosuvastatin Calcium	Rosuvastatin Calcium	285	106
Gabapentin	Gabapentin	240	74
Metoprolol Succinate	Metoprolol Succinate	236	73
Alendronate Sodium	Alendronate Sodium	195	55
Simvastatin	Simvastatin	183	57
Hydrochlorothiazide	Hydrochlorothiazide	168	50
Pravastatin Sodium	Pravastatin Sodium	154	49
Albuterol Sulfate Hfa	Albuterol Sulfate	145	62
Eliquis	Apixaban	130	31
Trazodone Hcl	Trazodone Hcl	128	44
Fluticasone Propionate	Fluticasone Propionate	122	51
Celecoxib	Celecoxib	121	37
Metoprolol Tartrate	Metoprolol Tartrate	118	38
Tramadol Hcl	Tramadol Hcl	118	21
Escitalopram Oxalate	Escitalopram Oxalate	112	30
Tizanidine Hcl	Tizanidine Hcl	111	41
Zolpidem Tartrate	Zolpidem Tartrate	110	32
Carvedilol	Carvedilol	109	33
Sertraline Hcl	Sertraline Hcl	107	34
Meloxicam	Meloxicam	101	48
Glimepiride	Glimepiride	100	32
Atenolol	Atenolol	98	26
Citalopram Hbr	Citalopram Hydrobromide	91	26
Pantoprazole Sodium	Pantoprazole Sodium	89	31
Tamsulosin Hcl	Tamsulosin Hcl	89	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	28
Duloxetine Hcl	Duloxetine Hcl	84	25
Famotidine	Famotidine	78	28
Furosemide	Furosemide	77	34
Metformin Hcl Er	Metformin Hcl	77	21
Montelukast Sodium	Montelukast Sodium	76	28
Prednisone	Prednisone	75	45
Allopurinol	Allopurinol	73	22
Ventolin Hfa	Albuterol Sulfate	68	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	14
Warfarin Sodium	Warfarin Sodium	60	13
Jardiance	Empagliflozin	56	21
Xarelto	Rivaroxaban	56	17
Ezetimibe	Ezetimibe	54	19
Tolterodine Tartrate Er	Tolterodine Tartrate	52	16
Azithromycin	Azithromycin	51	48
Pregabalin	Pregabalin	51	16
Acyclovir	Acyclovir	50	20
Diazepam	Diazepam	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Potassium Chloride	Potassium Chloride	49	22
Bupropion Xl	Bupropion Hcl	48	12
Chlorthalidone	Chlorthalidone	48	15
Clopidogrel	Clopidogrel Bisulfate	48	18
Hydroxyzine Hcl	Hydroxyzine Hcl	48	19
Hydralazine Hcl	Hydralazine Hcl	46	13
Ipratropium Bromide	Ipratropium Bromide	46	17
Ketoconazole	Ketoconazole	46	15
Sumatriptan Succinate	Sumatriptan Succinate	45	12
Amitriptyline Hcl	Amitriptyline Hcl	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	44	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	11
Valacyclovir	Valacyclovir Hcl	42	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	13
Buspirone Hcl	Buspirone Hcl	39	19
Ibuprofen	Ibuprofen	39	17
Nystatin	Nystatin	38	14
Estradiol	Estradiol	37	14
Lorazepam	Lorazepam	37	15
Ozempic	Semaglutide	36	11
Paroxetine Hcl	Paroxetine Hcl	36	12
Alprazolam	Alprazolam	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Klor-Con M20	Potassium Chloride	35	11
Baclofen	Baclofen	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	13
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Trulicity	Dulaglutide	32	11
Synthroid	Levothyroxine Sodium	31	suppressed
Ondansetron Odt	Ondansetron	30	11
Meclizine Hcl	Meclizine Hcl	28	11
Nitroglycerin	Nitroglycerin	28	15
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Glipizide	Glipizide	27	11
Tradjenta	Linagliptin	27	suppressed
Valsartan	Valsartan	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	11
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Fluconazole	Fluconazole	25	18
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	23
Spironolactone	Spironolactone	25	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	14
Clonazepam	Clonazepam	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	11
Doxycycline Hyclate	Doxycycline Hyclate	22	14
Myrbetriq	Mirabegron	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Finasteride	Finasteride	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Topiramate	Topiramate	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Dulera	Mometasone/Formoterol	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Metronidazole	Metronidazole	19	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Glipizide Er	Glipizide	18	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Cephalexin	Cephalexin	16	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Naproxen	Naproxen	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Cefadroxil	Cefadroxil	13	11
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Glyburide	Glyburide	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Lyrica	Pregabalin	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Atovaquone-Proguanil Hcl	Atovaquone/Proguanil Hcl	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error